Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
BioNTech SE
Stephen J Thomas; Edson D Moreira; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Fernando P Polack; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Xia Xu; Satrajit Roychoudhury; Kenneth Koury; Salim Bouguermouh; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Qi Yang; Paul Liberator; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; William C Gruber; Kathrin U Jansen; C4591001 Clinical Trial Group